These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21872585)

  • 41. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1.
    Hammad H; de Heer HJ; Soullie T; Hoogsteden HC; Trottein F; Lambrecht BN
    J Immunol; 2003 Oct; 171(8):3936-40. PubMed ID: 14530310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contractile effects of 15-E2t-isoprostane and 15-F2t-isoprostane on chicken embryo ductus arteriosus.
    van der Sterren S; Villamor E
    Comp Biochem Physiol A Mol Integr Physiol; 2011 Aug; 159(4):436-44. PubMed ID: 21565280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel antagonist of CRTH2 blocks eosinophil release from bone marrow, chemotaxis and respiratory burst.
    Royer JF; Schratl P; Lorenz S; Kostenis E; Ulven T; Schuligoi R; Peskar BA; Heinemann A
    Allergy; 2007 Dec; 62(12):1401-9. PubMed ID: 17714552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor.
    Monneret G; Gravel S; Diamond M; Rokach J; Powell WS
    Blood; 2001 Sep; 98(6):1942-8. PubMed ID: 11535533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C.
    Hamid-Bloomfield S; Payne AN; Petrovic AA; Whittle BJ
    Br J Pharmacol; 1990 Aug; 100(4):761-6. PubMed ID: 2119842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of MK-0524, a prostaglandin D(2) receptor antagonist, on prostaglandin D (2)-induced nasal airway obstruction in healthy volunteers.
    Van Hecken A; Depré M; De Lepeleire I; Thach C; Oeyen M; Van Effen J; Laethem T; Mazina K; Crumley T; Wenning L; Gottesdiener KM; Deutsch P; Clement P; Lai E; de Hoon JN
    Eur J Clin Pharmacol; 2007 Feb; 63(2):135-41. PubMed ID: 17200838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of NP-1815-PX, a P2X4 Receptor Antagonist, on Contractions in Guinea Pig Tracheal and Bronchial Smooth Muscles.
    Obara K; Inaba R; Kawakita M; Murata A; Yoshioka K; Tanaka Y
    Biol Pharm Bull; 2022; 45(8):1158-1165. PubMed ID: 35908896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complement C5a exhibits anxiolytic-like activity via the prostaglandin D2-DP1 receptor system coupled to adenosine A2A and GABAA receptors.
    Miyamoto C; Yoshida M; Yoshikawa M; Mizushige T; Ohinata K
    Prostaglandins Other Lipid Mediat; 2012 May; 98(1-2):17-22. PubMed ID: 22503964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Docosahexaenoic acid and eicosapentaenoic acid strongly inhibit prostanoid TP receptor-dependent contractions of guinea pig gastric fundus smooth muscle.
    Xu K; Shimizu M; Murai C; Fujisawa M; Ito D; Saitoh N; Nakagome Y; Yamashita M; Murata A; Oikawa S; Ou G; Yoshioka K; Obara K; Tanaka Y
    Pharmacol Res Perspect; 2022 Jun; 10(3):e00952. PubMed ID: 35466586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the prostaglandin D2 receptors DP and CRTH2 for treatment of inflammation.
    Ulven T; Kostenis E
    Curr Top Med Chem; 2006; 6(13):1427-44. PubMed ID: 16918458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PGD(2) modulates fibroblast-mediated native collagen gel contraction.
    Kohyama T; Wyatt TA; Liu X; Wen FQ; Kobayashi T; Fang Q; Kim HJ; Rennard SI
    Am J Respir Cell Mol Biol; 2002 Sep; 27(3):375-81. PubMed ID: 12204901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel PGD(2) receptor expressed in eosinophils.
    Powell WS
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):179-85. PubMed ID: 12895601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor.
    Johnston SL; Freezer NJ; Ritter W; O'Toole S; Howarth PH
    Eur Respir J; 1995 Mar; 8(3):411-5. PubMed ID: 7789486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel indole compound, AWT-489, inhibits prostaglandin D2-induced CD55 expression by acting on DP prostanoid receptors as an antagonist in LS174T human colon cancer cells.
    Oyama S; Fujino H; Yamazaki R; Okura I; Regan JW; Awata A; Arai T; Murayama T
    Arch Biochem Biophys; 2014 Jan; 541():21-9. PubMed ID: 24239863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of thromboxane receptor activation in the bronchospastic response to endothelin.
    Schumacher WA; Steinbacher TE; Allen GT; Ogletree ML
    Prostaglandins; 1990 Jul; 40(1):71-9. PubMed ID: 2143841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostaglandin D2 receptors DP and CRTH2 in the pathogenesis of asthma.
    Arima M; Fukuda T
    Curr Mol Med; 2008 Aug; 8(5):365-75. PubMed ID: 18691063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostaglandin D2 induces heme oxygenase-1 mRNA expression through the DP2 receptor.
    Satarug S; Wisedpanichkij R; Takeda K; Li B; Na-Bangchang K; Moore MR; Shibahara S
    Biochem Biophys Res Commun; 2008 Dec; 377(3):878-83. PubMed ID: 18957281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostaglandin D
    Guan NN; Svennersten K; de Verdier PJ; Wiklund NP; Gustafsson LE
    J Cell Mol Med; 2017 Feb; 21(2):234-243. PubMed ID: 27664012
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 1. Bicyclo[2.2.1]heptane derivatives.
    Mitsumori S; Tsuri T; Honma T; Hiramatsu Y; Okada T; Hashizume H; Inagaki M; Arimura A; Yasui K; Asanuma F; Kishino J; Ohtani M
    J Med Chem; 2003 Jun; 46(12):2436-45. PubMed ID: 12773047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Docosahexaenoic acid inhibits U46619- and prostaglandin F
    Yoshioka K; Obara K; Oikawa S; Uemura K; Yamaguchi A; Fujisawa K; Hanazawa H; Fujiwara M; Endoh T; Suzuki T; De Dios Regadera M; Ito D; Ou G; Xu K; Tanaka Y
    Eur J Pharmacol; 2021 Oct; 908():174371. PubMed ID: 34329614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.